The Big Story
-
The Big Story
No More TV Drug Ads? Don’t Hold Your Breath
Does the incoming Trump administration and RFK Jr.’s potential appointment as the head of Health and Human Services (HHS) spell the end of TV drug ads? Probably not, argues Josh Walsh, CEO and co-founder of BranchLab, a data science firm for health care advertisers, and this week’s guest on The Big Story. Efforts to crack down […]
From
-
The Big Story
Political Advertising Post-Mortem Analysis, Part Deux
Jessica Alter, co-founder of the nonprofit Tech for Campaigns, believes political campaigns should model their digital ad strategy on that of seed-stage startups. She joins the podcast this week to talk through this year’s unexpected election results.
From
-
The Big Story
The Role Of Ad Dollars In The 2024 Presidential Election
Trump won the 2024 election. To discuss how paid media played a role (and didn’t) in his victory, we bring on guest Jordan Lieberman, CEO of Power Interactive. The programmatic buying company handled more than 1,000 digital campaigns across the political spectrum this election cycle.
From
-
The Big Story
The Culture Clash Underneath Creative Ad Tech
To explain Forrester’s latest creative ad tech wave, we bring on author, Senior Analyst Nikhil Lai. Then, the untold story of how Prebid.org became an independent industry organization.
From
-
The Big Story
The Curation Debate
We discuss the rise of curation in programmatic buying and the current backlash. Is curation an ad network with new window dressing? And will it save or undermine the open web?
From
-
The Big Story
Unboxing Amazon Ads’ Ad Tech
From the Amazon Ads Unboxed conference, AdExchanger reports on the ad tech products it’s building. Plus, why brand safety and news publishers remain at odds with each other, and what each side is doing about it.
From
-
The Big Story
Is The Trade Desk A Hero Or Villain To Independent Ad Tech?
As The Trade Desk grows more powerful, it’s attracting more attention – and frustration – from independent ad tech. Plus: an update on Google Chrome’s user choice mechanism.
From
-
The Big Story
The US v. Google Witnesses Have Spoken – Now What?
It’s a wrap on the US v. Google antitrust case, at least for now. Then, behind the IP infringement claim on the OpenRTB spec that ruffled feathers at the IAB Tech Lab.
From
-
The Big Story
Waiting On A Judge And The Polls
Hear what the ad tech industry is saying about Google’s antitrust trial. Then, a rundown on how the election is playing out for political advertisers and news publishers.
From
-
The Big Story
View From The US v. Google Trial Press Box
After eight days of the antitrust trial, who’s in the lead: the DOJ or Google? Details on the most gripping testimony so far with guest Arielle Garcia, director of intelligence for Check My Ads.
From
